Canagliflozin for Japanese patients with chronic heart failure and type II diabetes

BACKGROUND: Reports that sodium glucose cotransporter 2 inhibitors decrease cardiovascular death and events in patients with diabetes have attracted attention in the cardiology field. We conducted a study of canagliflozin in patients with chronic heart failure and type II diabetes. METHODS: Thirty-f...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cardiovasc Diabetol
Main Authors: Sezai, Akira, Sekino, Hisakuni, Unosawa, Satoshi, Taoka, Makoto, Osaka, Shunji, Tanaka, Masashi
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2019
Fag:
Original Investigation
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6551875/
https://ncbi.nlm.nih.gov/pubmed/31167663
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0877-2
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker